Tazmo (6266) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
21 Jul, 2026Executive summary
FY2025 saw steady sales and profits in semiconductor and surface treatment equipment, with advanced packaging applications driving growth in the Process Equipment Business.
Net sales for FY2025 were ¥35,428 million, down 1.2% year-over-year, with operating profit at ¥4,768 million, a 19.4% decrease from the prior year.
Ordinary profit declined 16.5% to ¥5,009 million, and profit attributable to owners of parent fell 16.6% to ¥3,541 million year-over-year.
Surface Treatment Equipment Business achieved higher profits despite market slowdown, aided by improved estimation accuracy and project completions.
Comprehensive income dropped to ¥3,345 million from ¥4,788 million in FY2024.
Financial highlights
Gross profit decreased to ¥10,759 million from ¥11,855 million year-over-year.
Operating margin for FY2025 was 13.5%, down from 16.5% in the previous year.
Free cash flow improved to ¥6,244 million.
Cash flows from operating activities improved to ¥9,425 million (after correction), up from ¥7,507 million.
Cash and cash equivalents at year-end rose to ¥13,947 million from ¥9,733 million.
Outlook and guidance
FY2026 net sales are estimated at ¥35,500 million, nearly flat year-over-year.
Operating income is forecast at ¥3,600 million, a 24.5% decrease.
Net income is projected at ¥2,500 million, down 29.4%.
Basic earnings per share forecast for FY2026 is ¥170.65.
Dividend per share is forecast at ¥34.0, with a payout ratio of 19.9%.
Latest events from Tazmo
- Q1 FY2026 saw sharp declines in sales and profit, but order intake for key segments surged.6266
Q1 202621 Jul 2026 - Strong sales and profit growth led to a higher outlook and dividend forecast for 2024.6266
Q2 202421 Jul 2026 - Net sales up 30% and operating profit up 91% year-over-year, led by semiconductor equipment.6266
Q3 202421 Jul 2026 - Net income surged 80.2% YoY; FY2025 sees higher sales but lower profits and rising dividends.6266
Q4 202421 Jul 2026 - Operating income exceeded plan despite lower sales, but profits and comprehensive income declined.6266
Q2 202521 Jul 2026 - Operating income more than doubled, but comprehensive income fell on currency losses.6266
Q1 202521 Jul 2026 - Net sales up 9.6% year-over-year, but profit guidance revised downward for full-year 2025.6266
Q3 202521 Jul 2026